Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (34 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 31 Jul 2023 – 20 Aug 2026, limited by LIC MF Mid Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | LIC MF Mid Cap Fund | Nifty Midcap 150 |
|---|---|---|
| 31 Jul 2023 | ₹100.00 | ₹100.00 |
| 01 Nov 2023 | ₹102.45 | ₹102.86 |
| 02 Feb 2024 | ₹120.95 | ₹126.40 |
| 05 May 2024 | ₹132.14 | ₹133.72 |
| 06 Aug 2024 | ₹151.27 | ₹145.76 |
| 07 Nov 2024 | ₹154.61 | ₹149.89 |
| 08 Feb 2025 | ₹144.78 | ₹140.17 |
| 12 May 2025 | ₹145.81 | ₹143.79 |
| 13 Aug 2025 | ₹150.64 | ₹148.99 |
| 14 Nov 2025 | ₹156.62 | ₹157.93 |
| 15 Feb 2026 | ₹152.10 | ₹154.77 |
| 19 May 2026 | ₹154.68 | ₹158.24 |
| 20 Aug 2026 | ₹169.27 | ₹165.41 |
| Metric | LIC · Direct NAV ₹35.78 Very High risk ★★☆☆☆ | Category median Mid Cap Fund · 34 funds |
|---|---|---|
| +9.80% | +9.87% | |
| +19.23% | +19.74% | |
| — | +17.84% | |
| — | +17.01% | |
| +18.80% | +19.29% | |
| +13.02% | — | |
| +19.23% | +20.53% | |
| — | +19.07% | |
| — | +18.49% | |
| Risk | ||
| 16.68% | 16.20% | |
| 0.76 | 0.83 | |
| 1.04 | 1.14 | |
| -21.47% | -32.95% | |
| Nifty Midcap 150 | — | |
| +0.98% | +2.33% | |
| 1.02 | 0.94 | |
| 102.7% | 98.4% | |
| 99.0% | 87.8% | |
| 1.78% | 0.97% | |
| ₹350.29Cr | ₹7,594Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹200 | — | |
| ₹5.00K | — | |
| 37% | 40% | |
| Karan Doshi · 3.1y | — | |
| 31 Jul 2023 | — | |
| 65 | — | |
| 25.8% | — | |
| 3.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.